Kymera Therapeutics, Inc. (KYMR) — Analyst estimates
Consensus analyst estimates for Kymera Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 10.74M | -1.01 | 10 |
| 2027 | 12.50M | -1.05 | 6 |
| 2028 | 41.24M | -4.68 | 14 |
| 2029 | 51.73M | -4.75 | 8 |
| 2030 | 228.03M | -3.61 | 12 |
Consensus analyst estimates by fiscal year.